(Q42504483)

1 November 2017

Effects of lovastatin on natural killer cell function and other immunological parameters in man. (English)

1 reference

1 November 2017

1 reference

R McPherson

1

1 reference

1 November 2017

C Tsoukas

2

1 reference

1 November 2017

M G Baines

3

1 reference

1 November 2017

A Vost

4

1 reference

1 November 2017

M R Melino

5

1 reference

1 November 2017

R V Zupkis

6

1 reference

1 November 2017

H F Pross

7

1 reference

1 November 2017

1 November 1993

1 reference

Journal of Clinical Immunology

1 November 2017

1 reference

1 November 2017

13

1 reference

1 November 2017

439-444

1 reference

1 November 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00920019

1 November 2017

0 references

cites work

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

12 December 2020

Detection of familial hypercholesterolemia by assaying functional low-density-lipoprotein receptors on lymphocytes

1 reference

12 December 2020

Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2.

1 reference

12 December 2020

Promotion of lymphocyte growth by high density lipoproteins (HDL). Physiological significance of the HDL binding site

1 reference

12 December 2020

Modulation of human lymphocyte responses by low density lipoproteins (LDL): enhancement but not immunosuppression is mediated by LDL receptors

1 reference

12 December 2020

Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation

1 reference

12 December 2020

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

1 reference

12 December 2020

The standardization of NK cell assays for use in studies of biological response modifiers

1 reference

12 December 2020

Might treatment of hypercholesterolaemia increase non-cardiac mortality?

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes

1 reference

12 December 2020

Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia

1 reference

12 December 2020

Cellular cholesterol metabolism in mitogen-stimulated lymphocytes--requirement for de novo synthesis

1 reference

12 December 2020

Suppression of lymphoid cell function in vitro by inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by lovastatin

1 reference

12 December 2020

Role of mevalonic acid in the regulation of natural killer cell cytotoxicity

1 reference

12 December 2020

Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation

1 reference

12 December 2020

Lymphocyte activation

1 reference

12 December 2020

Biology of natural killer cells

1 reference

12 December 2020

Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00920019

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference